Group Leader
Alex Rovira Cañellas
Principal Investigator (PI)
Deborah Pareto
Researchers
Carlos Tortajada, Cristina Auger, Juli Alonso, Xavier Aymerich, Silvana Sarria, Gerard Martí, Sofía Sceppacuercia
Lab Technicians
Juan F. Corral, Manel Alberich
Nursing and Technical Staff
Elena Huerga, Ana María Nieto
27
PUBLICATIONS
251
IMPACT FACTOR
9.31
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Torres-Ferrus M, Pareto D, Gallardo VJ, Cuberas-Borrós G, Alpuente A, Caronna E, Vila-Balló A, Lorenzo-Bosquet C, Castell-Conesa J, Rovira A, Pozo-Rosich P.
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18 FDG-PET and MRI study
J Headache Pain. 2021 Jul 17;22(1):75
DOI: 10.1186/s10194-021-01289-5
IF: 7.28
Alonso J, Pareto D, Alberich M, Kober T, Maréchal B, Lladó X, Rovira A.
Quantitative comparison of subcortical and ventricular volumetry derived from MPRAGE and MP2RAGE images using different brain morphometry software.
MAGMA. 2021 Dec;34(6):903-914
DOI: 10.1007/s10334-021-00933-0
IF: 2.31
Rovira A, Corral JF, Auger C, Valverde S, Vidal-Jordana A, Oliver A, de Barros A, Ng Wong YK, Tintoré M, Pareto D, Aymerich FX, Montalban X, Lladó X, Alonso J.
Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients
Mult Scler . 2021 Dec 3;13524585211061339.
DOI: 10.1177/13524585211061339
IF: 6.31
Midaglia L, Sastre-Garriga J, Pappolla A, Quibus L, Carvajal R, Vidal-Jordana A, Arrambide G, Río J, Comabella M, Nos C, Castilló J, Galan I, Rodríguez-Acevedo B, Auger C, Tintoré M, Montalban X, Rovira À.
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia
Mult Scler . 2021 May;27(6):913-921
DOI: 10.1177/1352458520988148
IF: 6.31
Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
Lancet Neurol. 2021 Aug;20(8):653-670.
DOI: 10.1016/S1474-4422(21)00095-8
IF: 44.18
TReatment And VISual Recovery in Optic Neuritis – The TRAVIS study
Principal Investigator: Jaume Sastre-Garriga, Alex Rovira Cañellas
Agency: Instituto de Salud Carlos III
Funding: 99,704€
Period: 2020-2022
Structural-functional spinal characterization by magnetic resonance imaging. Application in multiple sclerosis
Principal Investigator: Deborah Pareto
Agency: Instituto de Salud Carlos III
Funding: 40,293 €
Period: 2019-2021
Cortical and lesion remyelination in relapsing-remitting multiple sclerosis patients from the Opicinumab (Anti-LINGO-1) phase II clinical trial (Synergy). A validation study of the T1-weighted and T2-weighted ratio approach (RAPOR)
Principal Investigator: Deborah Pareto
Agency: Biogen
Funding: 60,000€
Period: 2019-2021
Neurosciences
- Research group on Status Epilepticus and Acute Seizures
- Neuroradiology
- Stroke Research
- Gene Therapy at Nervous System
- Clinical and Translational Bioinformatics
- Peripheral Nervous System
- Headache and Neurological Pain
- Cell signaling and Apoptosis
- Neurodegenerative Diseases
- Neurotraumatology and Neurosurgery Research Unit (UNINN)
- Clinical Neuroimmunology
- Pediatric Neurology
- Psychiatry, Mental Health and Addictions
- Neuromuscular and Mitochondrial Pathology